From sicca to malignant evolution: a swift turn to multiple myeloma in primary Sjögren’s syndrome

Authors

  • Sreeja Mogiligari Department of Clinical Immunology and Rheumatology, ESIC Medical College and Super Speciality Hospital, Sanathnagar, Hyderabad, Telangana, India
  • Vijaya P. Parimi Department of Clinical Immunology and Rheumatology, ESIC Medical College and Super Speciality Hospital, Sanathnagar, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20262203

Keywords:

Primary Sjögren's syndrome, Multiple myeloma, Vasculitic skin lesions

Abstract

Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disorder characterized by exocrine gland involvement and systemic B cell hyperactivity. Although hematologic complications are recognized, transformation to multiple myeloma (MM) remains exceptionally uncommon. We report a 50-year-old woman who presented with constitutional symptoms, sicca manifestations and recurrent vasculitic skin lesions. Evaluation established a diagnosis of primary Sjögren’s syndrome with associated monoclonal gammopathy of undetermined significance (MGUS). Despite initial management and follow up, she subsequently developed worsening systemic symptoms accompanied by progressive extra glandular manifestations, prompting reassessment. Serial investigations confirmed progression to multiple myeloma within a relatively short interval. The patient was managed collaboratively by rheumatology and hematology departments and showed favorable clinical and laboratory response to therapy. This case highlights a rare malignant evolution in pSS and underscores the importance of maintaining a high index of suspicion in patients with persistent systemic symptoms, paraproteinemia, vasculitic manifestations or unexplained clinical deterioration. Careful longitudinal monitoring may facilitate earlier recognition of hematologic transformation and enable timely therapeutic intervention, potentially improving patient outcomes.

References

Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X. Primary Sjögren syndrome. BMJ. 2012;14:344.

Fauchais AL, Martel C, Gondran G, Lambert M, Launay D, Jauberteau MO, et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev. 2010;9(9):595-9.

Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome. Arthritis Rheum. 1999;42(8):1765-72.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, e al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-48.

Moutsopoulos HM, Steinberg AD, Fauci AS, Lane HC, Papadopoulos NM. High incidence of free monoclonal light chains in the sera of patients with Sjögren's syndrome. J Immunol. 1983;130:2663-5.

Moutsopoulos HM, Costello R, Drosos A, Mavridis AK, Papadopoulos NM. Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis. 1985;44:109-12.

Ota T, Wake A, Eto S, Kobayashi T. Sjögren's syndrome terminating with multiple myeloma. Scand J Rheumatol. 1995;24:316-8.

Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Landgren O. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: a population-based study. Blood. 2014;123(5):686-94.

Sivils KL, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a systematic review. Clin Exp Rheumatol. 2016;34(1):S85-S92.

Pasoto SG, Adriano de Oliveira Martins V, Bonfá E. Sjögren’s Syndrome and Systemic Lupus Erythematosus: Links and Risks for Lymphoma Development. Autoimmun Rev. 2012;11(4):333-6.

Downloads

Published

2026-06-29

How to Cite

Mogiligari, S., & Parimi, V. P. (2026). From sicca to malignant evolution: a swift turn to multiple myeloma in primary Sjögren’s syndrome. International Journal of Research in Medical Sciences, 14(7), 3091–3094. https://doi.org/10.18203/2320-6012.ijrms20262203

Issue

Section

Case Reports